Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jun 1;73(6):834-836.
doi: 10.2337/dbi24-0019.

A Golden Hour and Golden Opportunity for β-Cell Preservation

Carmella Evans-Molina  1   2   3   4 , Richard A Oram  5   6   7
Affiliations
Editorial

A Golden Hour and Golden Opportunity for β-Cell Preservation

Carmella Evans-Molina et al. Diabetes. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Duality of Interest. C.E.-M. has served on advisory boards for Isla Technologies, Avotres, DiogenX, and Neurodon. She is a member of the INNODIA external advisory board, has received in-kind research support from Bristol Myers Squibb and Nimbus Pharmaceuticals, and is the recipient of investigator-initiated grants from Lilly Pharmaceuticals and Astellas Pharmaceuticals. R.A.O. has served as a consultant for Sanofi Pharmaceuticals, ProventionBio, and Janssen Pharmaceuticals. R.A.O. had a U.K. Medical Research Council confidence-in-concept award to develop a T1D Genetic Risk Score biochip with Randox R & D and has ongoing research funding from Randox Laboratories Ltd. No other potential conflicts of interest relevant to this article were reported.

Comment on

References

    1. Insel RA, Dunne JL, Atkinson MA, et al. . Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015;38:1964–1974 - PMC - PubMed
    1. Evans-Molina C, Oram RA. Teplizumab approval for type 1 diabetes in the USA. Lancet Diabetes Endocrinol 2023;11:76–77 - PubMed
    1. Sanofi . Q4 2023 Results: Play to win, 2024. Accessed 12 March 2024. Available from https://www.sanofi.com/assets/dotcom/content-app/events/quaterly-results...
    1. Gregory GA, Robinson TIG, Linklater SE, et al. .; International Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group . Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol 2022;10:741–760 - PubMed
    1. Latres E, Greenbaum CJ, Oyaski ML, et al. . Evidence for C-peptide as a validated surrogate to predict clinical benefits in trials of disease-modifying therapies for type 1 diabetes. Diabetes 2024;73:823–833 - PubMed

MeSH terms

Substances